×

AthenaDAO Launches Its $ATH Token

Web3 takes on the radically underfunded women’s health space.

Share







AthenaDAOAthenaDAO

Mark your calendars: The opportunity to get in early and shape the most expansive and undertapped area of biotech is just days away. AthenaDAO, the one of the largest DeSci DAOs and the first to focus on women’s health, is launching their capped ERC20 governance token ($ATH) on August 31st at 12pm CET, with the auction running just five days, until September 5 at 12pm EST.

DeSci, the Real-World Use Case Crypto Deserves

AthenaDAO is part of the Decentralized Science (DeSci) movement. DeSci is a space on the rise, proving the real-world impact blockchain and Ethereum can have in the scientific method and the biotech industry. Featuring open, modular data and new capital allocation through primitives like IP-NFTs, DeSci is reimagining scientific progress from step one.

Women: The Most Significant Growth Market

“We have an opportunity here to onboard the next wave of mission-driven users into web3 and what could be more powerful than the mission to advance women’s health?” shares Laura Minquini, founder and core lead of AthenaDAO.

Despite women accounting for half of the world’s population, their health is largely overlooked. It was called the “best and most underfinanced investment” by the World Economic Forum this year, with menopause alone estimated to be a $600 billion market. With a strong pipeline including a stealth company in formation, research in PCOS & Endometriosis, a data aggregation platform for women’s health, and more, AthenaDAO is poised to flip the full ecosystem on its head—and showcase the impact of web3 stack in the process.

Introducing $ATH

The AthenaDAO ecosystem relies on its utility governance token, $ATH. Holders have the opportunity to guide the direction of the DAO, voting on key decisions like supporting research projects and developing governance policies. In designing their auction, AthenaDAO included cheeky nods to the community they’re serving: The floor price will be listed at 12.5¢, symbolizing the average age girls begin their periods, and there will be 2 million tokens available, equal to the average number of eggs girls are born with. Tokenomics details can be found in their whitepaper.

ADVERTISEMENT

Eterna is a clothing company with a focus on longevity.

The Auction Details

Running from August 31 at 12pm CET until September 5 at 12pm EST on bio.xyz’s new launchpad, the $ATH token sale will happen via batch auction for optimal price discovery and fair participation. Those interested in participating in the auction are encouraged to whitelist, join AthenaDAO’s Discord, and subscribe to auction calendar notifications to ensure they don’t miss a beat. To note: The team is committed to absolute compliance and will be geoblocking US addresses during the auction.

For More Information

Website: athenadao.co

Discord: AthenaDAO

X/Twitter: @athena_dao_

For all additional information, quotes, and interview requests, please contact Erin Dahl, [email protected].

ADVERTISEMENT

An advertisement banner for PartiQular supplements.

About AthenaDAO

AthenaDAO is a community-driven organization enabling translational women’s health research, education, and funding . AthenaDAO has received research proposals from Cambridge, Harvard, MIT, and more. Launched in August 2022, they have published two Reproductive Health Reports, grown their community to 5k+ members, hosted & attended 30+ events, minted 1 IP-NFT with 2 pending, and were selected on the first cohort of BioDAO accelerator bio.xyz.

About bio.xyz

bio.xyz is the home for decentralized biotech, accelerating the next generation of science with capital, talent and resources to build the biotech DAOs (BioDAOs) and DeSci projects of the future. The AthenaDAO auction will run on bio.xyz’s new BioDAO launchpad, the token launch platform for DeSci builders.

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?
CategoryPress Releases